Shamik Majumdar
About Shamik Majumdar
Shamik Majumdar is a Research Fellow currently at The National Institutes of Health, specializing in immunophenotyping and host-virus interactions. He has a PhD in Immunology from the Indian Institute of Science and has extensive experience in immunology research, including a long tenure at the National Institute of Allergy and Infectious Diseases.
Work at National Institutes of Health
Shamik Majumdar currently serves as a Research Fellow at the National Institutes of Health (NIH), a position he has held since 2023. In this role, he contributes to ongoing research initiatives, focusing on immunology and related fields. The NIH is a leading biomedical research agency in the United States, providing a platform for advanced scientific inquiry and collaboration.
Education and Expertise
Shamik Majumdar earned his Doctor of Philosophy (PhD) in Immunology from the Indian Institute of Science (IISc) between 2011 and 2017. His academic background also includes a Master of Science (MS) in Virology from the National Institute of Virology, India, completed from 2009 to 2011. His educational journey has equipped him with specialized knowledge in immunophenotyping, host-virus interactions, and chemokine research.
Background
Shamik Majumdar began his research career at the Indian Institute of Science (IISc) in Bengaluru, Karnataka, India, where he worked as a Doctoral Researcher from 2011 to 2017. Following his doctoral studies, he joined the National Institute of Allergy and Infectious Diseases (NIAID) as a Visiting Fellow, where he worked for 12 years until 2023. His extensive experience spans both Indian and American research institutions.
Research Specialization
Shamik Majumdar specializes in immunology, with a focus on immunophenotyping, host-virus interactions, and chemokine research. His research aims to understand the complex dynamics between hosts and viruses, contributing to the broader field of immunological studies. This specialization is critical for advancing knowledge in infectious diseases and developing potential therapeutic strategies.